Meetings & Events

LYUMJEV™ (insulin lispro-aabc) Injection

August 27, 2020

Product Theater Details: 3:35–4:35 PM EDT on Friday, September 11, 2020

Presenter: Thomas C. Blevins, MD
Texas Diabetes and Endocrinology

This program will discuss LYUMJEV, a mealtime insulin option for adult patients living with type 1 and type 2 diabetes. Attendees will join a discussion on the efficacy, safety profile, and appropriate prescribing of this therapy. In addition, this program will review patient initiation on LYUMJEV regarding dosing and administration. There will also be an opportunity to ask the faculty questions about the data presented.

This program is sponsored by and the speaker is presenting on behalf of Lilly Diabetes. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.